Laura Chico Score: 32
Analyst at
Wedbush
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-17.4%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
28%
7 W / 18 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
73%
8 W / 3 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
18%
2 W / 9 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
9%
1 W / 10 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
36%
5 W / 9 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
18%
3 W / 14 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
50%
4 W / 4 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 01, 2026 |
Edgewise Therapeutics Inc
EWTX
|
BUY |
$52.00
Est. +29%
|
$40.26 | $40.77 |
Pending
|
$34.83
-13.5%
|
| May 14, 2026 |
Alto Neuroscience Inc.
ANRO
|
BUY |
$24.00
Est. +5%
|
$22.85 | $23.91 |
Bullseye Hit (±1%)
|
$21.47
-6.0%
|
| May 13, 2026 |
PepGen Inc
PEPG
|
BUY |
$4.00
Est. +147%
|
$1.62 | $1.82 |
Pending
|
$1.47
-9.3%
|
| May 11, 2026 |
Jade Biosciences, Inc.
JBIO
|
BUY |
$34.00
Est. +32%
|
$25.81 | $26.83 |
Pending
|
$15.34
-40.6%
|
| May 08, 2026 |
Denali Therapeutics Inc
DNLI
|
BUY |
$23.00
Est. +14%
|
$20.11 | $22.15 |
Pending
|
$21.66
+7.7%
|
| Apr 08, 2026 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$31.00
Est. +114%
|
$14.47 | $20.00 |
Pending
|
$16.35
+13.0%
|
| Mar 03, 2026 |
Larimar Therapeutics Inc
LRMR
|
BUY |
$12.00
Est. +119%
|
$5.48 | $6.00 |
Pending
|
$3.47
-36.7%
|
| Feb 10, 2026 |
Biogen Inc
BIIB
|
SELL |
$187.00
Est. +3%
|
$192.72 | $168.64 (Low) |
Target Met
|
$200.05
-3.8%
|
| Dec 11, 2025 |
Vera Therapeutics Inc - Ordinary Shares - Class A
VERA
|
SELL |
$33.00
Est. +27%
|
$45.42 | $30.59 (Low) |
Target Met
|
$34.26
+24.6%
|
| Dec 11, 2025 |
Denali Therapeutics Inc
DNLI
|
BUY |
$30.00
Est. +70%
|
$17.61 | $23.46 |
Pending
|
$21.66
+23.0%
|
| Dec 05, 2025 |
Denali Therapeutics Inc
DNLI
|
BUY |
$31.00
Est. +54%
|
$20.11 | $23.46 |
Pending
|
$21.66
+7.7%
|
| Oct 03, 2024 |
Larimar Therapeutics Inc
LRMR
|
BUY |
$22.00
Est. +250%
|
$6.29 | $9.50 |
Miss
|
$3.47
-44.8%
|
| Sep 23, 2024 |
Biogen Inc
BIIB
|
BUY |
$205.00
Est. +3%
|
$199.36 | $199.99 |
Precision Hit (±3%)
|
$200.05
+0.3%
|
| Aug 09, 2024 |
Xenon Pharmaceuticals Inc
XENE
|
BUY |
$49.00
Est. +19%
|
$41.05 | $46.00 |
Miss
|
$52.10
+26.9%
|
| May 14, 2024 |
Voyager Therapeutics Inc
VYGR
|
SELL |
$8.00
Est. +6%
|
$8.48 | $2.75 (Low) |
Target Met
|
$3.50
+58.7%
|
| Apr 25, 2024 |
Biogen Inc
BIIB
|
BUY |
$215.00
Est. +5%
|
$204.65 | $237.98 |
Target Met
|
$200.05
-2.2%
|
| Mar 21, 2024 |
Vera Therapeutics Inc - Ordinary Shares - Class A
VERA
|
SELL |
$34.00
Est. +21%
|
$42.87 | $25.99 (Low) |
Target Met
|
$34.26
+20.1%
|
| Sep 25, 2023 |
Pharvaris NV
PHVS
|
BUY |
$27.00
Est. +31%
|
$20.67 | $21.54 |
Miss
|
$30.72
+48.6%
|
| Aug 07, 2023 |
Biogen Inc
BIIB
|
SELL |
$269.00
Est. +1%
|
$271.23 | $196.90 (Low) |
Target Met
|
$200.05
+26.2%
|
| Dec 29, 2022 |
Ardelyx Inc
ARDX
|
SELL |
$2.00
Est. +15%
|
$2.34 | - | - |
$5.69
-143.2%
|
| Apr 09, 2022 |
Biogen Inc
BIIB
|
SELL |
$185.00
Est. +14%
|
$214.75 | - | - |
$200.05
+6.8%
|
| Nov 09, 2021 |
Apellis Pharmaceuticals Inc
APLS
|
SELL |
$28.00
Est. +25%
|
$37.34 | - | - |
$41.03
-9.9%
|
| Nov 03, 2021 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$92.00
Est. +7%
|
$86.00 | - | - |
$24.35
-71.7%
|
| Aug 04, 2021 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$112.00
Est. +20%
|
$93.20 | - | - |
$159.76
+71.4%
|
| Aug 03, 2021 |
Sage Therapeutics Inc
SAGE
|
BUY |
$80.00
Est. +92%
|
$41.76 | - | - |
$8.68
-79.2%
|
Edgewise Therapeutics Inc
EWTX
Jun 01, 2026
Signal & Target
BUY
$52.00
Start Price
$40.26
Best Price (1Y)
$40.77
Current Price
$34.83
Return
-13.5%
Alto Neuroscience Inc.
ANRO
May 14, 2026
Signal & Target
BUY
$24.00
Start Price
$22.85
Best Price (1Y)
$23.91
Current Price
$21.47
Return
-6.0%
PepGen Inc
PEPG
May 13, 2026
Signal & Target
BUY
$4.00
Start Price
$1.62
Best Price (1Y)
$1.82
Current Price
$1.47
Return
-9.3%
Jade Biosciences, Inc.
JBIO
May 11, 2026
Signal & Target
BUY
$34.00
Start Price
$25.81
Best Price (1Y)
$26.83
Current Price
$15.34
Return
-40.6%
Denali Therapeutics Inc
DNLI
May 08, 2026
Signal & Target
BUY
$23.00
Start Price
$20.11
Best Price (1Y)
$22.15
Current Price
$21.66
Return
+7.7%
Viridian Therapeutics Inc
VRDN
Apr 08, 2026
Signal & Target
BUY
$31.00
Start Price
$14.47
Best Price (1Y)
$20.00
Current Price
$16.35
Return
+13.0%
Larimar Therapeutics Inc
LRMR
Mar 03, 2026
Signal & Target
BUY
$12.00
Start Price
$5.48
Best Price (1Y)
$6.00
Current Price
$3.47
Return
-36.7%
Biogen Inc
BIIB
Feb 10, 2026
Signal & Target
SELL
$187.00
Start Price
$192.72
Best Price (1Y)
$168.64
Current Price
$200.05
Return
-3.8%
Signal & Target
SELL
$33.00
Start Price
$45.42
Best Price (1Y)
$30.59
Current Price
$34.26
Return
+24.6%
Denali Therapeutics Inc
DNLI
Dec 11, 2025
Signal & Target
BUY
$30.00
Start Price
$17.61
Best Price (1Y)
$23.46
Current Price
$21.66
Return
+23.0%
Denali Therapeutics Inc
DNLI
Dec 05, 2025
Signal & Target
BUY
$31.00
Start Price
$20.11
Best Price (1Y)
$23.46
Current Price
$21.66
Return
+7.7%
Larimar Therapeutics Inc
LRMR
Oct 03, 2024
Signal & Target
BUY
$22.00
Start Price
$6.29
Best Price (1Y)
$9.50
Current Price
$3.47
Return
-44.8%
Biogen Inc
BIIB
Sep 23, 2024
Signal & Target
BUY
$205.00
Start Price
$199.36
Best Price (1Y)
$199.99
Current Price
$200.05
Return
+0.3%
Xenon Pharmaceuticals Inc
XENE
Aug 09, 2024
Signal & Target
BUY
$49.00
Start Price
$41.05
Best Price (1Y)
$46.00
Current Price
$52.10
Return
+26.9%
Voyager Therapeutics Inc
VYGR
May 14, 2024
Signal & Target
SELL
$8.00
Start Price
$8.48
Best Price (1Y)
$2.75
Current Price
$3.50
Return
+58.7%
Biogen Inc
BIIB
Apr 25, 2024
Signal & Target
BUY
$215.00
Start Price
$204.65
Best Price (1Y)
$237.98
Current Price
$200.05
Return
-2.2%
Signal & Target
SELL
$34.00
Start Price
$42.87
Best Price (1Y)
$25.99
Current Price
$34.26
Return
+20.1%
Pharvaris NV
PHVS
Sep 25, 2023
Signal & Target
BUY
$27.00
Start Price
$20.67
Best Price (1Y)
$21.54
Current Price
$30.72
Return
+48.6%
Biogen Inc
BIIB
Aug 07, 2023
Signal & Target
SELL
$269.00
Start Price
$271.23
Best Price (1Y)
$196.90
Current Price
$200.05
Return
+26.2%
Ardelyx Inc
ARDX
Dec 29, 2022
Signal & Target
SELL
$2.00
Start Price
$2.34
Best Price (1Y)
-
Current Price
$5.69
Return
-143.2%
Biogen Inc
BIIB
Apr 09, 2022
Signal & Target
SELL
$185.00
Start Price
$214.75
Best Price (1Y)
-
Current Price
$200.05
Return
+6.8%
Apellis Pharmaceuticals Inc
APLS
Nov 09, 2021
Signal & Target
SELL
$28.00
Start Price
$37.34
Best Price (1Y)
-
Current Price
$41.03
Return
-9.9%
Ultragenyx Pharmaceutical Inc.
RARE
Nov 03, 2021
Signal & Target
BUY
$92.00
Start Price
$86.00
Best Price (1Y)
-
Current Price
$24.35
Return
-71.7%
Neurocrine Biosciences, Inc.
NBIX
Aug 04, 2021
Signal & Target
BUY
$112.00
Start Price
$93.20
Best Price (1Y)
-
Current Price
$159.76
Return
+71.4%
Sage Therapeutics Inc
SAGE
Aug 03, 2021
Signal & Target
BUY
$80.00
Start Price
$41.76
Best Price (1Y)
-
Current Price
$8.68
Return
-79.2%